Kidney Transplantation — CPB 0493 | AETNA Coverage Update

TL;DR: Aetna, a CVS Health company, modified CPB 0493 governing kidney transplantation coverage policy, effective December 18, 2025. Billing teams need to audit medical necessity documentation, understand which monitoring codes are now explicitly excluded, and verify that transplant candidate records meet all updated selection criteria before submitting claims.

---

Quick-Reference Table

Field	Detail Copy
Payer	Aetna, a CVS Health company
Policy	Kidney Transplantation
Policy Code	CPB 0493
Change Type	Modified
Effective Date	December 18, 2025
Impact Level	High
Specialties Affected	Nephrology, Transplant Surgery, Urology, Oncology, Infectious Disease, Cardiology
Key Action	Audit transplant candidate documentation against all updated medical necessity criteria and confirm excluded monitoring codes (0088U, 0493U, 0526U, 0540U, 0544U, 81558) are not on your charge capture

---

Aetna Kidney Transplantation Coverage Criteria and Medical Necessity Requirements 2025

Aetna's kidney transplantation coverage policy under CPB 0493 Aetna system sets up a two-track approval path. If your transplant center has documented selection criteria, Aetna defers to those. If the institution lacks a formal protocol, Aetna applies its own nine-part medical necessity checklist — and every condition must be satisfied simultaneously.

The lead criterion is transplant committee acceptance. The member must complete a full evaluation and be accepted by the kidney transplant committee at the transplanting center. Aetna explicitly flags a common confusion point here: a request for transplant evaluation is not the same as a request for transplantation itself. Precertification for the transplant depends on what that evaluation finds — document this distinction clearly in your prior authorization submission.

Age eligibility defers to the transplanting institution's protocol. Beyond age, Aetna requires absence of malignancy — with narrow exceptions. Non-melanomatous skin cancers and low-grade prostate cancer are allowed. Other malignancies qualify only if curative therapy is complete or the estimated recurrence risk is below 10% within two years. Examples in the policy include renal cell carcinoma post-nephrectomy with no metastatic disease after two years, prostate cancer with negative PSA after treatment, surgically treated colon cancer, and thyroid cancer with normal thyroglobulin after therapy. Female candidates must have a negative Pap smear within three years and mammography within two years — attach those results to the prior authorization packet.

For HIV-positive members, Aetna sets four simultaneous thresholds: CD4 count above 200 cells/mm³ for more than six months, undetectable HIV-1 RNA viral load, stable antiretroviral therapy for more than three months, and no AIDS-related complications such as opportunistic infections, Kaposi's sarcoma, or other neoplasms. Miss any one of these and the transplant does not qualify.

Cardiovascular, pulmonary, and hepatic risk assessments must come from the attending physician — and the policy uses "prohibitive" as the standard. Your documentation needs the physician's explicit finding that no prohibitive risk exists in each of those three categories. A note that says "cardiac workup completed" is not enough.

Severity thresholds for kidney transplant billing depend on donor type. For cadaveric kidney transplantation, the member must either already be on hemodialysis or CAPD — CPT codes 90918–90925 cover these ESRD services — or have severe chronic renal failure with a creatinine clearance below 30 ml/min and anticipated progression to ESRD. Aetna acknowledges that cadaveric wait times average one to four years, which is why precertification is available before the member reaches dialysis. For living donor transplantation, the bar is ESRD itself: creatinine clearance below 20 ml/min or symptomatic uremia.

The core transplant procedure codes — CPT 50300, 50320, 50340, 50360, 50365, 50370, 50380, and 50547 — are covered when selection criteria are met. Backbench preparation codes 50323, 50325, 50327, 50328, and 50329 are also covered under the same conditions. Reimbursement for these codes depends entirely on documented compliance with the criteria above.

---

Aetna Kidney Transplantation Exclusions and Non-Covered Indications

Several absolute contraindications disqualify a member from kidney transplant coverage under this policy. Active vasculitis is a hard stop. So is age over 70 with severe comorbidities, life-threatening extra-renal congenital abnormalities, and ongoing alcohol or drug abuse. These exclusions are not a complete list — the policy says so explicitly — but they are the clearest claim denial triggers to watch for in your documentation review.

The bigger billing issue for most teams is the monitoring and rejection-surveillance code exclusions. Aetna explicitly denies coverage for several post-transplant monitoring technologies under CPB 0493. These include:

Donor-derived cell-free DNA testing — marketed under brand names like Allosure — has no specific coverage position in this policy. CPT codes 0493U, 0508U, 0509U, 0540U, and 0544U all fall into this "no specific coverage" bucket. That is not the same as covered, and it is not the same as explicitly excluded. If you are billing these codes for Aetna transplant patients, expect inconsistent adjudication and build your appeal documentation now. Talk to your compliance officer about how to handle these in your charge capture before December 18, 2025.

DNA methylation biomarker codes 0018M, 0319U, and 0320U are grouped separately under a post-transplantation complications category — again without a clear covered or not-covered determination in the summary data. Flag these for review.

Panniculectomy and abdominoplasty — CPT 15830 and 15847 — are explicitly not covered for the indications listed in CPB 0493.

---

Coverage Indications at a Glance

---

Aetna Kidney Transplantation Billing Guidelines and Action Items 2025

The effective date is December 18, 2025. Here is what your team needs to do before then.

Copy Action Items

---

CPT, HCPCS, and ICD-10 Codes for Kidney Transplantation Under CPB 0493

Covered CPT Codes (When Selection Criteria Are Met)

Not Covered CPT Codes

Codes with No Specific Coverage Position (Donor-Derived Cell-Free DNA Testing)

DNA Methylation and RNA Expression Codes (No Specific Coverage Position)

Code	Type	Description	Notes Copy
0018M	CPT	Transplantation medicine (allograft rejection, renal), measurement of donor and third-party-induced alloresponse	Listed under DNA methylation as biomarker of post-transplantation complications
0319U	CPT	Nephrology (renal transplant), RNA expression by select transcriptome sequencing, using pre-transplant peripheral blood	Listed under DNA methylation/RNA expression category
0320U	CPT	Nephrology (renal transplant), RNA expression by select transcriptome sequencing, using post-transplant peripheral blood	Listed under DNA methylation/RNA expression category

Supporting Documentation Codes — Female Transplant Candidates

---